For healthy BRCA1/2 mutation carriers, the options are to follow a BC surveillance program aimed at early BC detection, or to opt for bilateral risk-reducing mastectomy (BRRM) to reduce BC risk. This evidence concerns the gene BRCA1 and breast cancer.